Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (171-180 of 415) with videos related to

Pageof 42
Sort By:
BMC Infectious Diseases|September 23, 2015
Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort StudyJim Young, Martin Rickenbach, Alexandra Calmy, et al.
Lancet (London, England)|May 25, 2023
No time for complacency on COVID-19 in EuropeAntoine Flahault, Alexandra Calmy, Dominique Costagliola, et al.
The Journal of Infectious Diseases|October 31, 2009
Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional studyAlexandra Calmy, Christoph A Fux, Richard Norris, et al.
Journal of the International AIDS Society|November 11, 2024
Patient and public involvement in HIV research: a mapping review and development of an online evidence mapDavid Jackson-Perry, Ellen Cart-Richter, David Haerry, et al.
Plos One|October 23, 2015
Frequency of and Risk Factors for Depression among Participants in the Swiss HIV Cohort Study (SHCS)Alexia Anagnostopoulos, Bruno Ledergerber, René Jaccard, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2011
Ageing with HIV: medication use and risk for potential drug-drug interactionsCatia Marzolini, David Back, Rainer Weber, et al.
AIDS (London, England)|November 15, 2014
Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in SwitzerlandAysel Gueler, Franziska Schoeni-Affolter, André Moser, et al.
Plos Biology|September 17, 2014
Disentangling human tolerance and resistance against HIVRoland R Regoes, Paul J McLaren, Manuel Battegay, et al.
AIDS (London, England)|May 9, 2009
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trialAlexandra Calmy, Angele Gayet-Ageron, Fabrizio Montecucco, et al.
AIDS (London, England)|May 20, 2011
A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study)Alain Nguyen, Alexandra Calmy, Cecile Delhumeau, et al.
Pageof 42

Showing results (171-180 of 415) with videos related to

Sort By:
Pageof 42
BMC Infectious Diseases|September 23, 2015
Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort StudyJim Young, Martin Rickenbach, Alexandra Calmy, et al.
Lancet (London, England)|May 25, 2023
No time for complacency on COVID-19 in EuropeAntoine Flahault, Alexandra Calmy, Dominique Costagliola, et al.
The Journal of Infectious Diseases|October 31, 2009
Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional studyAlexandra Calmy, Christoph A Fux, Richard Norris, et al.
Journal of the International AIDS Society|November 11, 2024
Patient and public involvement in HIV research: a mapping review and development of an online evidence mapDavid Jackson-Perry, Ellen Cart-Richter, David Haerry, et al.
Plos One|October 23, 2015
Frequency of and Risk Factors for Depression among Participants in the Swiss HIV Cohort Study (SHCS)Alexia Anagnostopoulos, Bruno Ledergerber, René Jaccard, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2011
Ageing with HIV: medication use and risk for potential drug-drug interactionsCatia Marzolini, David Back, Rainer Weber, et al.
AIDS (London, England)|November 15, 2014
Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in SwitzerlandAysel Gueler, Franziska Schoeni-Affolter, André Moser, et al.
Plos Biology|September 17, 2014
Disentangling human tolerance and resistance against HIVRoland R Regoes, Paul J McLaren, Manuel Battegay, et al.
AIDS (London, England)|May 9, 2009
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trialAlexandra Calmy, Angele Gayet-Ageron, Fabrizio Montecucco, et al.
AIDS (London, England)|May 20, 2011
A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study)Alain Nguyen, Alexandra Calmy, Cecile Delhumeau, et al.
Pageof 42